Ozone Therapy in the Prevention of COVID-19 Infection

NCT04400006 | Completed

• 1 other identifier: 2761
• Study Type: observational
• Target: 71
• Locations: 1 country
• Sites: 1

Brief Summary

Coronavirus has already infected 4,673,809 people and killed 312,646 people worldwide, and no specific treatment or a vaccine against it has yet proven to be effective. Ozone therapy has become o promising tool for both prevention and treatment of COVID-19 infection by various possible mechanisms. The oxidative stress created by ozone in the body to stimulate the peripheral phagocytic cells, activate the antioxidant system, and restore the immune system is thought to be effective for the prevention of COVID-19 infection. In recent years, ozone therapy has become a popular alternative method for chronic pain management of various diseases such as fibromyalgia, knee osteoarthritis, and rheumatic diseases. As a result of this, there were many individuals who had received ozone therapy before the outbreak of COVID-19. This study aimed to investigate the preventive effect of ozone therapy against COVID-19 infection in these individuals.

Conditions

Corona Virus Infection

Keywords

Coronavirus; Ozone; Preventive Medicine

Outcome Measures

Primary Outcomes (1)

• The survey that was taken by telephone calls

  It involved questions about age, gender, height, weight, occupation, comorbidities, and concurrent medications, in addition to a detailed query for COVID-19 infection

  Day 0

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Individuals who completed at least ten sessions of ozone therapy applied by the method of major autohemotherapy\* in the last six months from the time the first COVID-19 case of Turkey reported (Mar 11, 2020).

You may qualify if:

• To be completed at least ten sessions of ozone therapy applied by the method of major autohemotherapy in the last six months from the time the first COVID-19 case of Turkey reported (Mar 11, 2020)

You may not qualify if:

• To received ozone therapy locally or fewer than ten sessions
• not want to participate

Sponsors & Collaborators

• Marmara University: lead

Study Sites (1)

Kardelen Gencer Atalay

Istanbul, 34899, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronavirus Infections

Condition Hierarchy (Ancestors)

Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections

Study Officials

• Kardelen Gencer

  Marmara University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 21, 2020
• First Posted: May 22, 2020
• Study Start: May 6, 2020
• Primary Completion: May 16, 2020
• Study Completion: May 17, 2020
• Last Updated: May 22, 2020

Record last verified: 2020-05

Locations

TU (1)